Schedule 13D ownership disclosure
Keenova Therapeutics PLC
Security class unavailable · CUSIP: G5890A102
Event date: 2024-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,789,673
- Percent of class
- 9.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-24-000675
- Form type
- SC 13D
- Filer
- Hein Park Capital Management LP
- CIK
- CIK 1826937
- Filed
- Jun 26, 2024
- Reporting period
- Jun 24, 2024
- Description
- Schedule 13D beneficial ownership